24.04.2017 • NewsElaine BurridgeHanwhaethylene

Hanwha-Total JV Hikes Ethylene Output

(c) George Clerk/Getty Images
(c) George Clerk/Getty Images

Hanwha Total Petrochemical, the 50:50 joint venture between South Korean conglomerate Hanwha and French energy group Total, will spend $450 million to increase ethylene production at Daesan.

The expansion, which will raise the cracker’s capacity by 30% to 1.4 million t/y, will significantly increase the site’s flexibility, enabling it to process propane feedstock, which the company said is abundantly available and competitively priced as a result of US shale developments. The project is scheduled to complete by mid-2019.

The additional output will meet local demand as well as supply the fast-growing Chinese market, which imports a significant portion of its ethylene requirements.

“This project is part of our strategy to invest in world-class integrated platforms to develop petrochemicals based on competitive feedstock and targeting high-growth markets,” said Bernard Pinatel, President of Total Refining & Chemicals “The investment reflects the strong partnership with Hanwha and will contribute to the growth of our refining & petrochemicals cash flows.

Daesan is one of Total’s six integrated platforms and a strategic asset for Hanwha. The site, which is comprised of a highly flexible condensate splitter, steam cracker and units for polymers, styrene and aromatics, generated a net result of nearly $1 billion in 2016.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read